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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A396Figure 2. Mean histological scores of the tibia plateaus. Left bar group:
Mean histological scores of the medial tibia plateaus of the rights knees in
the untreated and PC-treated guinea pigs. Right bar group: Mean histo-
logical scores of the lateral tibia plateaus of the right knees in the
untreated and PC-treated guinea pigs. * ¼ P < 0.05 PC-treated versus the
untreated guinea pigs.
Figure 3. Cartilage thickness. Left: thickness of the medial tibia cartilage in
the untreated guinea pigs. Right: thickness of the medial tibia cartilage in
the PC-treated guinea pigs.
Figure 4. Immunostaining scores. Left bar group: MMP-15 immunostain-
ing. Middle bar group: ADAMTS5 immunostaining. Right bar group: CCL-5
immunostaining.
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THE IN VIVO AND IN VITRO EFFECT OF INHIBITORS OF BRD4 AND
CDK9 ON EARLY PHASE OF POST TRAUMATIC OSTEOARTHRITIS
T. Fukui, J.H. Yik, D.R. Haudenschild. Lawrence J. Ellison Musculoskeletal
Res. Ctr., Sacramento, CA, USA
Purpose: Joint trauma is a risk factor for osteoarthritis (OA), and about
50% of patients with ACL or meniscal injury develop posttraumatic OA
(PTOA) within 10-20 years. The acute response to joint trauma increases
transcription of pro-inﬂammatory cytokines and proteinases such as
matrix metalloproteinases (MMPs), which trigger the onset of OA
changes. Bromodomain protein 4 (Brd4) and cyclin-dependent kinase 9
(CDK9) control the rate-limiting step of the transcription of primary
response genes, including most pro-inﬂammatory genes, by positively
regulating mRNA elongation with phosphorylating and releasing the
RNA polymerase II. The purpose of this study is to investigate the effects
of small molecule inhibitors of Brd4 (JQ1) and CDK9 (Flavopiridol) on
the activation of inﬂammatory genes using chondrocytes and cartilage
tissue under inﬂammatory stimuli, and a mouse PTOA model.
Methods:
 Treatment of chondrocytes Human chondrocytes were cultured 5
hours with inﬂammatory stimuli (either 10ng/ml IL1b, 10ng/ml TNFa, or
100ng/ml IL6 and 60ng/ml IL6 receptor), with or without drugs.
Treatment conditions were: 1) vehicle only (Ctrl), 2) no drug with
cytokine, 3) Hi JQ1 (1200nM) with cytokine, 4) Hi Flavopiridol (250nM)
with cytokine, 5) Combination of Lo JQ1 (250nM) and Lo Flavopiridol
(60nM) with cytokine. Total RNA was extracted and analyzed by real
time RT-PCR and microarray. Treatment of cartilage explants
Bovine cartilage explants were isolated and randomly assigned to 5
groups cultured as described above, with the cytokine being 10ng/ml
IL1b. Glycosaminoglycan (GAG) released into the culture media was
measured.
 PTOA animal model
The right knees of mice were injured with a mechanical compression,
which causes rupture of the anterior cruciate ligament and leads to
PTOA. Immediately after injury, mice were treated daily with JQ1 and/or
Flavopiridol. Treatment conditions were: 1) vehicle only (Ctrl), 2) Hi JQ1
(50mg/kg), 3) Hi Flavopiridol (7.5mg/kg), 4) Combination of Lo JQ1
(17mg/kg) and Lo Flavopiridol (2.5mg/kg) Flavopiridol.
 MMPSense Assay
To assess MMP activity, MMPSense 750 was injected to mice and the
intensity of signal from the MMPSense in the knees was measured by in
vivo imaging.
Results:
 The mRNA expression levels of pro-inﬂammatory genes (iNOS, Cox2)
and catabolic genes (MMP-1, -3, -9, and -13, and ADAMTS4) were sig-
niﬁcantly induced by all 3 inﬂammatory cytokines, and this induction
was suppressed by all 3 drug treatments. The combination of both drugs
at lower doses suppressed gene expression similarly or more strongly
than single high doses of each individual drug.
Microarray showed that expression, 873 geneswere induced >1.5-fold
by IL1b compared to baseline. IL-1b treatment in the presence of either
JQ1 or Flavopiridol alone prevented the induction of many genes.
However, a combination of both drugs prevented the induction of most
IL-1b response genes. (Fig.1)
 IL1b treatment of cartilage explants induced signiﬁcant release of GAG
within 3-6 days. GAG release was effectively prevented when IL-1b
treatment in the presence of either or both drugs. (Fig2)
 In PTOAmouse model, knee injury caused signiﬁcant increases of IL1b
and IL6 expression in the injured joint. All 3 treatments showed effect to
prevent increases of these cytokines and drug combination was more
effective than single drugs. (Fig3A, B) MMP activity in injured knee was
suppressed by all 3 treatment similarly at 24h and 48h after injury.
(Fig3C, D)
Conclusions: JQ1 and Flavopiridol are each able to effectively repress a
panel of pro-inﬂammatory and catabolic genes in chondrocytes induced
by inﬂammatory stimulus. We found that the combination of the 2
drugs showed a synergistic interaction, with similar or better repression
achieved at reduced drug doses. Although previous reports indicated
that Brd4 and CDK9 control mRNA transcription by regulating a com-
mon checkpoint, microarray analysis showed that there were also
inﬂammatory genes only affected by each drug individually. Ex vivo and
in vivo study also demonstrated the combination of lower dose of the
drugs has similar or better intensity of effect. This indicates that using
both drugs together may be able to suppress inﬂammation after trauma
with preventing side effects induced by overdose, leading to novel
treatment for PTOA.
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SYNTHESIS AND CHARACTERIZATION OF GOLD NANOPARTICLES
COMBINED WITH CURCUMIN AND ITS EFFECT ON EXPERIMENTAL
OSTEOARTHRITIS IN MICE
W. N. Silva Campos, V.S. Marangoni, D.A. Sonego, M.A. Andrade,
E.M. Colodel, R.L. de Souza, Sr.. FEDERAL Univ. of Mato Grosso, Cuiaba,
Brazil
Purpose: The aim of study was the synthesis and characterization of a
system combining gold nanoparticles (AuNPs) to curcumin and eval-
uate its therapeutic potential in an experimental model of osteoarthitis
(OA) in mice by destabilization of the medial meniscus (DMM).
Methods: Thirty two C57BL6 strain male mice, 8 weeks of age, were
used. For the experimental induction of osteoarthitis we used DMM
destabilization technique proposed by Glasson et al. (2007). For the
synthesis of AuNPs we used the hydrochloride polyallylamine (PAH) as
a stabilizer and sodium borohydride as a reducer agent and character-
izations were performed by UV-VIS spectroscopy, dynamic light scat-
tering (DLS) and determination zeta potential. Four groups were
formed, each with eight animals, named as A (360 mg of AUNP-PAH), B
(20 mg of curcumin), C (360mg of AUNP-PAH-Curcumin) and D (sham)
thus distributed in accordance with the administered therapy. All ani-
mals were treated with three applications by intra-articular injection,
every 15 days, with the beginning of the treatment was given on day 14
after induction of OA. After 6 weeks of induction of OA, the animals
were euthanized. All knee joint (KJ) were ﬁxed in 10% buffered formalin
for 24 hours and decalciﬁed in EDTA solution monosodium 15% for two
weeks. They were then processed according to routine procedures and
the slides stained with hematoxylin and eosin (H&E) and Safranin O fast
green to evaluate the concentration of proteoglycans. These were
assessed by 2 independent observers in a blind study, using the criteria
established by Mankin et al. (1971). By which a score of each joint was
obtained by calculating the formula, standardized by the evaluation
system of Osteoarthritis Research Society International (OARSI), andestablished by Bao et al. (2009) and Rutgers et al. (2010), thus, each KJ
received a score ranging from 0 to 24. Data were analyzed for normal
distribution using the Kolmogorov-Smirnov test. Therefore, normal
datawere submitted to analysis of variance, and, in cases of signiﬁcance,
means were compared using the Tukey test. For all statistical analysis
was adopted the 5% signiﬁcance level.
Results: Histological analyzes showed a clear distinction of articular
cartilage damage among the different groups. Focal discontinuity of
cartilage surface area and erosion with loss of surface lesions were
found more often in groups A (360 mg of AUNP-PAH) and B (20 mg of
curcumin), and loss of proteoglycans, as evidenced by decreased
safranin O staining fast green. KJ in group C (360mg of AUNP-PAH-
Curcumin), there was edema and ﬁbrillation of the cartilage surface
were the most frequent changes, emphasizing greater dial proteogly-
cans. While in the D (sham) group, there were injuries such as
microfractures with presence of ﬁbrocartilage, remodeling and bone
repair. With regard to the mean values score, there was a greater value
in group D KJ, with a mean score of 18.25. In addition, there was
signiﬁcant difference (p 0.05) between these groups. C group animals
showed a signiﬁcant decrease (p <0.001) in their scoring average
values in the control group, however there was no statistical difference
with the other groups.
Conclusions: The results show the importance of the study and
development of new nanodrugs. Despite the solutions studied have
shown similarity to each other, one should consider that animals
treatedwith the solution of AUNP-PAH-Curcumin, presented less severe
in the histological lesions. Further studies evaluating the expression of
antiinﬂammatory genes and pro-inﬂammatory, catabolic and anabolic
mediators are needed to demonstrate the effective role of this ther-
apeutic option in the treatment of OA.
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THE EFFECTS OF SIMVASTATIN ON THE SYMPTOMS OF KNEE
OSTEOARTHRITIS(KOA) DURING A 3-MONTH TREATMENT COURSE
IN A SAMPLE OF IRAQI PATIENTS
S. Salman, A.A. Mohammad. Coll. of Med., Baghdad, Iraq
Purpose: Osteoarthritis is the most common form of arthropathy.
Matrix metalloproteinases (MMPs) and proinﬂammatory cytokines
such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor alpha (TNF-
a) play an important role in this condition. Statins show non lipid
modeﬁable effects, pleiotropic effects, which could be responsible for
their anti oxidative and anti inﬂammatory effect.
Methods: One hundred thirty (130) patients were randomly assigned to
receive oral simvastatin 20 mg once daily in (group A¼n 62), or placebo
(group B ¼n 68). The efﬁcacy outcome measure was the change in the
Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) including the pain, stiffness and physical function subscales.
Results: The mean pain score at ﬁrst visit (baseline) was (8.6±2.2) in
group A, vs. (6.98±2.2) in group B, P<0.001. At the second visit after one
month the pain scores in both groups were lowered down. Two month
later the pain score in group A decreased more while in group B was
slightly increased. After three month Pain score in group A continued to
decrease (5.14±2.9), while in group B there was a smaller change than
baseline with a mean difference of only (0.6 ± 0.57). The comparison in
mean differences of the baseline score vs. the last visit (after three
month) showed a signiﬁcantly higher change of pain score in group A
than in group B. The same trends had been observed in scales of stiff-
ness, physical function and total WOMAC, and the mean changes in
WOMAC scales in group A than group B.
Conclusions: The ﬁndings of this study indicate that simvastatin at the
oral once-daily dosage of 20 mg is more effective than placebo in
treating knee OA symptoms.
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DO PHYSICIANS TREAT OSTEOARTHRITIS PROPERLY IN CHINA:
ANALYSIS OF 67382 OUT-PATIENTS FROM PEKING UNIVERSITY
PEOPLE'S HOSPITAL
H. Zhang, L. Jiang, Z. Li, X. Dong, Q. Zhong, J. Lin. Peking Univ. People’s
Hosp., Beijing, China
Purpose: There is a high prevalence of osteoarthritis(OA) in old pop-
ulation, and physicans usually treat OA based on the guideline recom-
mended by OARSI. Until now, there is no report about the treatment in
